Topics

European Court of Justice backs UK in pay-for-delay fine against GSK

03:45 EST 14 Feb 2020 | Generics and Biosimilars Initiative

The European Court of Justice has backed an earlier decision by the UK financial regulator, the Competition and Markets Authority (CMA), to fine pharma giant GlaxoSmithKline (GSK) in connection with ‘pay for delay’ deals for one of its off-patent medications.

Original Article: European Court of Justice backs UK in pay-for-delay fine against GSK

NEXT ARTICLE

More From BioPortfolio on "European Court of Justice backs UK in pay-for-delay fine against GSK"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...